Labroots webinar: Introducing a streamlined solution to capture superior multiomic information at single-base resolution from limited DNA

Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
9:00 am
 to 9:45 am
 PDT, 
24 October 2023

Labroots webinar: Introducing a streamlined solution to capture superior multiomic information at single-base resolution from limited DNA

Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
Originally presented on 24 October 2023.

About the webinar

DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology in health and disease. The interaction of genetics with the epigenome plays a causal role in cell fate, ageing, and disease development. For example, modified cytosine profiles of cancer are differential from non-cancer, and genetic plus modified cytosine data together are more powerful for the detection of early cancer than either alone.   

Methods widely used to detect epigenetic DNA bases do not distinguish unmodified cytosines and thymine, therefore fail to capture common C-to-T mutations and thus capture incomplete genetic information. As a result, studies of genetics and methylation together require separate measurements of genetics and epigenetics, which present multiple challenges and complexities.  

We introduce duet multiomics solution +modC, a single base-resolution sequencing methodology that sequences complete genetics and cytosine modifications in a single workflow, enabling the identification of genetic variants and quantification of modified cytosine levels in a single experiment, at high accuracy for both genetics and epigenetics. 

This webinar was originally presented on Labroots.

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal